Report cover image

Global Angiotensin II Receptor Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 190 Pages
SKU # APRC20556707

Description

Summary

According to APO Research, the global Angiotensin II Receptor market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Angiotensin II Receptor is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Angiotensin II Receptor is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Angiotensin II Receptor market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Angiotensin II Receptor is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Angiotensin II Receptor market include CJ HealthCare Corp, MorphoSys AG, Vicore Pharma AB and Novartis AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Angiotensin II Receptor, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Angiotensin II Receptor, also provides the sales of main regions and countries. Of the upcoming market potential for Angiotensin II Receptor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Angiotensin II Receptor sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Angiotensin II Receptor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Angiotensin II Receptor sales, projected growth trends, production technology, application and end-user industry.

Angiotensin II Receptor Segment by Company

CJ HealthCare Corp
MorphoSys AG
Vicore Pharma AB
Novartis AG
Angiotensin II Receptor Segment by Type

MOR-107
KDT-501
EMA-401
C-21
Others
Angiotensin II Receptor Segment by Application

Women's Health
Immunology
Acute Ischemic Stroke
Respiratory
Others
Angiotensin II Receptor Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Angiotensin II Receptor status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Angiotensin II Receptor market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Angiotensin II Receptor significant trends, drivers, influence factors in global and regions.
6. To analyze Angiotensin II Receptor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiotensin II Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Angiotensin II Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiotensin II Receptor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Angiotensin II Receptor market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Angiotensin II Receptor industry.
Chapter 3: Detailed analysis of Angiotensin II Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Angiotensin II Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Angiotensin II Receptor in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Angiotensin II Receptor Sales Value (2020-2031)
1.2.2 Global Angiotensin II Receptor Sales Volume (2020-2031)
1.2.3 Global Angiotensin II Receptor Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Angiotensin II Receptor Market Dynamics
2.1 Angiotensin II Receptor Industry Trends
2.2 Angiotensin II Receptor Industry Drivers
2.3 Angiotensin II Receptor Industry Opportunities and Challenges
2.4 Angiotensin II Receptor Industry Restraints
3 Angiotensin II Receptor Market by Company
3.1 Global Angiotensin II Receptor Company Revenue Ranking in 2024
3.2 Global Angiotensin II Receptor Revenue by Company (2020-2025)
3.3 Global Angiotensin II Receptor Sales Volume by Company (2020-2025)
3.4 Global Angiotensin II Receptor Average Price by Company (2020-2025)
3.5 Global Angiotensin II Receptor Company Ranking (2023-2025)
3.6 Global Angiotensin II Receptor Company Manufacturing Base and Headquarters
3.7 Global Angiotensin II Receptor Company Product Type and Application
3.8 Global Angiotensin II Receptor Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Angiotensin II Receptor Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Angiotensin II Receptor Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Angiotensin II Receptor Market by Type
4.1 Angiotensin II Receptor Type Introduction
4.1.1 MOR-107
4.1.2 KDT-501
4.1.3 EMA-401
4.1.4 C-21
4.1.5 Others
4.2 Global Angiotensin II Receptor Sales Volume by Type
4.2.1 Global Angiotensin II Receptor Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Angiotensin II Receptor Sales Volume by Type (2020-2031)
4.2.3 Global Angiotensin II Receptor Sales Volume Share by Type (2020-2031)
4.3 Global Angiotensin II Receptor Sales Value by Type
4.3.1 Global Angiotensin II Receptor Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Angiotensin II Receptor Sales Value by Type (2020-2031)
4.3.3 Global Angiotensin II Receptor Sales Value Share by Type (2020-2031)
5 Angiotensin II Receptor Market by Application
5.1 Angiotensin II Receptor Application Introduction
5.1.1 Women's Health
5.1.2 Immunology
5.1.3 Acute Ischemic Stroke
5.1.4 Respiratory
5.1.5 Others
5.2 Global Angiotensin II Receptor Sales Volume by Application
5.2.1 Global Angiotensin II Receptor Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Angiotensin II Receptor Sales Volume by Application (2020-2031)
5.2.3 Global Angiotensin II Receptor Sales Volume Share by Application (2020-2031)
5.3 Global Angiotensin II Receptor Sales Value by Application
5.3.1 Global Angiotensin II Receptor Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Angiotensin II Receptor Sales Value by Application (2020-2031)
5.3.3 Global Angiotensin II Receptor Sales Value Share by Application (2020-2031)
6 Angiotensin II Receptor Regional Sales and Value Analysis
6.1 Global Angiotensin II Receptor Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Angiotensin II Receptor Sales by Region (2020-2031)
6.2.1 Global Angiotensin II Receptor Sales by Region: 2020-2025
6.2.2 Global Angiotensin II Receptor Sales by Region (2026-2031)
6.3 Global Angiotensin II Receptor Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Angiotensin II Receptor Sales Value by Region (2020-2031)
6.4.1 Global Angiotensin II Receptor Sales Value by Region: 2020-2025
6.4.2 Global Angiotensin II Receptor Sales Value by Region (2026-2031)
6.5 Global Angiotensin II Receptor Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Angiotensin II Receptor Sales Value (2020-2031)
6.6.2 North America Angiotensin II Receptor Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Angiotensin II Receptor Sales Value (2020-2031)
6.7.2 Europe Angiotensin II Receptor Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Angiotensin II Receptor Sales Value (2020-2031)
6.8.2 Asia-Pacific Angiotensin II Receptor Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Angiotensin II Receptor Sales Value (2020-2031)
6.9.2 South America Angiotensin II Receptor Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Angiotensin II Receptor Sales Value (2020-2031)
6.10.2 Middle East & Africa Angiotensin II Receptor Sales Value Share by Country, 2024 VS 2031
7 Angiotensin II Receptor Country-level Sales and Value Analysis
7.1 Global Angiotensin II Receptor Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Angiotensin II Receptor Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Angiotensin II Receptor Sales by Country (2020-2031)
7.3.1 Global Angiotensin II Receptor Sales by Country (2020-2025)
7.3.2 Global Angiotensin II Receptor Sales by Country (2026-2031)
7.4 Global Angiotensin II Receptor Sales Value by Country (2020-2031)
7.4.1 Global Angiotensin II Receptor Sales Value by Country (2020-2025)
7.4.2 Global Angiotensin II Receptor Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.5.2 USA Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.6.2 Canada Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.8.2 Germany Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.9.2 France Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.9.3 France Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.11.2 Italy Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.12.2 Spain Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.13.2 Russia Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.16.2 China Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.16.3 China Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.17.2 Japan Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.19.2 India Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.19.3 India Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.20.2 Australia Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.24.2 Chile Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.26.2 Peru Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.28.2 Israel Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.29.2 UAE Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.31.2 Iran Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Angiotensin II Receptor Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Angiotensin II Receptor Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Angiotensin II Receptor Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 CJ HealthCare Corp
8.1.1 CJ HealthCare Corp Comapny Information
8.1.2 CJ HealthCare Corp Business Overview
8.1.3 CJ HealthCare Corp Angiotensin II Receptor Sales, Value and Gross Margin (2020-2025)
8.1.4 CJ HealthCare Corp Angiotensin II Receptor Product Portfolio
8.1.5 CJ HealthCare Corp Recent Developments
8.2 MorphoSys AG
8.2.1 MorphoSys AG Comapny Information
8.2.2 MorphoSys AG Business Overview
8.2.3 MorphoSys AG Angiotensin II Receptor Sales, Value and Gross Margin (2020-2025)
8.2.4 MorphoSys AG Angiotensin II Receptor Product Portfolio
8.2.5 MorphoSys AG Recent Developments
8.3 Vicore Pharma AB
8.3.1 Vicore Pharma AB Comapny Information
8.3.2 Vicore Pharma AB Business Overview
8.3.3 Vicore Pharma AB Angiotensin II Receptor Sales, Value and Gross Margin (2020-2025)
8.3.4 Vicore Pharma AB Angiotensin II Receptor Product Portfolio
8.3.5 Vicore Pharma AB Recent Developments
8.4 Novartis AG
8.4.1 Novartis AG Comapny Information
8.4.2 Novartis AG Business Overview
8.4.3 Novartis AG Angiotensin II Receptor Sales, Value and Gross Margin (2020-2025)
8.4.4 Novartis AG Angiotensin II Receptor Product Portfolio
8.4.5 Novartis AG Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Angiotensin II Receptor Value Chain Analysis
9.1.1 Angiotensin II Receptor Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Angiotensin II Receptor Sales Mode & Process
9.2 Angiotensin II Receptor Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Angiotensin II Receptor Distributors
9.2.3 Angiotensin II Receptor Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.